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Background: Acute retention of urine (AROU) is commonly occurred in patients with geriatric hip frac-
tures after surgeries. It is common that the catheters cannot be weaned off after insertion.
Objectives: We compared an approach using uniﬁed Trial Without Catheter (TWOC) protocol with non-
uniﬁed management plans in patients with retention of urine after hip fracture surgery, to compare these
approaches in terms of (1) rate of successful catheter removal, (2) duration required for successful
catheter removal, (3) number of episodes of urinary tract infection, and (4) length of hospital stay.
Methods: We conducted a retrospective cohort study of 250 patients who failed to wean off a urinary
catheter. 140 out of 1349 patients between December 2012 and September 2014 formed the intervention
group (treated with uniﬁed TWOC protocol), and 110 out of 1193 patients between July 2006 and
December 2008 were the control group (treated with different AROU management approaches). The
efﬁciency and effectiveness of the urological management in both groups were compared.
Results: As expected, the rate of successful TWOC was higher in intervention group (before discharge,
68.6% versus 38.2%; after discharge, 20.0% versus 18.2%, overall, 88.6% versus 56.4%). Despite trial of
weaning off urinary catheters, 16 patients in intervention group and 8 patients in control group failed
with permanent catheter required. Forty patients in control group were discharged with permanently
catheters without a trial of TWOC.
Conclusion: The TWOC program provides structured and standardized urological management for pa-
tients suffered from AROU after geriatric hip fracture surgeries. To reiterate, indwelling urethral catheters
must not be placed permanently without carrying out urological assessment in patients with geriatric
hip fractures.
中 文 摘 要
背景 留置導尿管是常用於治理老年髖骨骨折併發急性尿瀦留的方法。自2012年起,我們採用了一個多學科的
臨床計劃（｢沒有導尿管試驗計劃｣,Trial Without a Catheter - TWOC）,以規範化急性尿瀦留的治理和之後拆
除導管的後續處理。
目標 我們從（1）拆除導尿管的成功率,（2）成功拆除導尿管需要的時間,（3）尿道感染的發病率,以及
（4）住院時間幾方面,來比較使用與不使用TWOC計劃的果效。
方法 我們回顧性研究了250個在髖部骨折手術後無法拆除導尿管的病人。當中140個病人(出自2012年12月
和2014年9月之間接受手術的1349個患者)組成實驗組（使用TWOC計劃）,另110個病人(出自2006年7月和
2008年12月之間接受手術的1193個患者) 組成對照組（不使用TWOC計劃）。
結果 實驗組擁有較高的拆除導尿管成功率（88.6％比56.4％,P <0.001）。儘管使用TWOC計劃,16名患者
需要使用永久性的導管。在對照組中有40例在出院時使用了永久性導管,而沒有嘗試拔除導尿管。
討論和結論 TWOC計劃規範化了老年髖骨骨折併發急性尿瀦留的處理。放置永久性的導尿管前應先由泌尿
外科醫生作評估。il.com, chengkhw@ha.org.hk.
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Acute retention of urine (AROU) is one of the most common
complications encountered during the acute and rehabilitation
periods in patients suffering from geriatric hip fractures. It is usu-
ally treated by insertion of indwelling urethral catheters.1,2 How-
ever, previous work has failed to deﬁne a standard for bladder
management in patients with geriatric hip fractures.3 The duration
of keeping the catheter in situ and the time of accessing interven-
tion from the urology team varies among patients in accordanceElderly 
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tract infection; OT ¼ operation.with the attending physician's judgement in our clinical setting.
Sometimes, the catheters are placed permanently without an
assessment by urologists. Unfortunately, AROU and the prolonged
use of indwelling urethral catheters increase the risk of urinary
tract infection (UTI)4 and stone formation.5 Moreover, the presence
of indwelling urethral catheters increases the unwillingness of
patients to return home or the reluctance of relatives to take pa-
tients home, leading to unnecessary stay in hospital.6,7 Therefore,
placing permanent indwelling urethral catheters in affected pa-
tients without urological treatment is a concern.with 
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was a multidisciplinary urological management protocol, was
implemented in our centre. The TWOC programme (Figure 1) was
designed under the collaboration of urologists, orthopaedic sur-
geons, ward nurses, urology nurses, day ward nurses, and com-
munity nurses. The programme took care of patients throughout
the acute, rehabilitation, and community phases by a multidisci-
plinary approach. It was initially designed to cover all eligible pa-
tients who suffered from hip fractures, lower limb fractures, and
pelvic fractures with conservative or surgical intervention. Our
study only focused on the patient group with geriatric hip fractures
that were treated with surgery.
Methods
We retrospectively reviewed the efﬁciency and effectiveness of
the TWOC programme with respect to the urological management
outcomes of patients with hip fractures in our orthopaedic reha-
bilitation centre. We included 250 patients with the following
criteria to the study: (1) were 65 years of age or older; (2) had
femoral neck, trochanteric, or subtrochanteric fractures; (3) un-
derwent surgery with internal ﬁxation or arthroplasty performed
under spinal or general anaesthesia; and (4) suffered from
retention of urine. Patients with (1) permanent urinary catheter
prior to admission, (2) active UTI, (3) obstructive uropathy, and (4)
urolithiasis causing hydronephrosis were excluded from the study.
Two separate urinary management approaches were imple-
mented for these patients. We used Altman's nomogram8 to es-
timate the sample size of patients that was necessary to have 90%
power to detect a 12-point difference in the catheter time be-
tween the two groups at the 5% signiﬁcance level. We assumed
that the standard deviation of the catheter time was ~15. We used
the nomogram to estimate the required sample sizes of two
groups, with d ¼ 12 and r ¼ 15. The standardized difference was d/
r ¼ 12/15 ¼ 0.80. The line connecting a standardized difference of
0.80 and a power of 90% cut the sample size axis at ~66. Therefore,
~33 patients were required for each group.
Intervention group
From December 2012 to September 2014, we had 1349 patients
who suffered from geriatric hip fractures and underwent surgery.
We deﬁned AROUwhen the postvoiding residual urine volumewas
> 300mL. Among these patients, 140 developed AROU. The patients
were managed according to a TWOC protocol. A bladder scan was
performed when AROU was suspected, irrespective of the time of
surgery. Bladder scan was also performed in all patients post-
operatively after removal of the urinary catheter to document the
residual urine volume. TWOC was considered successful if the pa-
tient was able to void and the residual urine volume was < 300 mL.
Afterwards, a postvoiding bladder scan would be repeated for two
more times to ascertain successful TWOC. Moreover, a bladder scan
would be performed again at any moment before discharge when
AROU was suspected.
The TWOC programme was developed based on the urological
management guidelines.9e16 Once AROU was detected, the imme-
diate treatment included the following: (1) insertion of an
indwelling urethral catheter for documentation of the residual
urine volume; (2) saving a urine sample for culture and sensitivity
test; (3) checking renal function; and (4) performing Kidney, Ureter
& Bladder (KUB) X-ray to look for urinary stones. UTIs that were
conﬁrmed by positive urine culture would be treated with antibi-
otics. If urinary stones were suspected, early ultrasonography of the
renal system would be arranged. Urologists would be consulted
directly if there was hydronephrosis or obvious renal impairmentthat responded to drainage of urine, signifying the presence of
obstructive uropathy.17
Prior to the trial of weaning off the urinary catheter, some
prerequisite actions including pain control, constipation, and hy-
dration management were carried out. The TWOCwould be carried
out according to the following schedule, counting from the date of
surgery. (1) TWOC would be carried out every 2 weeks after
insertion of a catheter during hospitalization. (2) When patients
failed to wean off a catheter before discharge, TWOC would be
carried out by a community nurse at home or at elderly homes at
the eighth week after surgery. TWOC would be carried out at the
surgical day ward when elderly homes were not covered by com-
munity nursing services. (3) If the TWOC in patients performed by a
community nurse or a day ward nurse failed, it would be carried
out by a urology nurse at the nurse clinic at twelfth week after
surgery. The urology nurse would also check for patient's voiding
efﬁciency, carry out some baseline urological investigations such as
uroﬂowmetry before attending urology specialist clinic, and pro-
vide education to patients.
In the sixteenth week, all the male patients inwhom TWOC was
successful or failed would be referred to a urology specialist to rule
out the possibility of prostatic or other urological pathology. Female
patients would be referred only to a specialist clinic when TWOC
was unsuccessful.
Control group
From July 2006 to December 2008, 1193 patients suffered from
geriatric hip fractures and underwent surgery. Patients were not
routinely assessed with a bladder scanner on admission. During
hospitalization, AROU would be suspected according to patients'
complaints, or when the nursing staff observed that patients failed
to void for several hours. AROU would be conﬁrmed by performing
a urinary bladder scanning. The criteria of deﬁning AROU varied
according to individual doctor's clinical judgement, with the post-
voiding residual urine volume being  500 mL. Among these pa-
tients, 110 developed AROU. Once AROU was detected, decisions
regarding the insertion of a urinary catheter, the plan of weaning off
the catheter, consultation with a surgeon, and a referral to a urol-
ogist clinic were made by the orthopaedic doctor in charge or the
surgeon after consultation. The immediate treatment included: (1)
insertion of an indwelling urethral catheter for documentation of
the residual urine volume and (2) saving a urine sample for culture
and sensitivity test. Symptomatic UTIs would be treated with an-
tibiotics. Investigations for obstructive uropathy, urinary stones,
and hydronephrosis were not performed.
Prior to the trial of weaning off a urinary catheter, no stan-
dardized prerequisite actions including pain control, constipation,
and hydration management were carried out. The TWOC would be
performed according to the following schedule: (1) during hospi-
talization, TWOC was carried out by ward nurses every 2 weeks
during the routine change of urinary catheter; (2) when patients
failed to wean off a catheter before discharge, no further TWOC
would be carried out. Catheters were changed on a biweekly basis
by community nurses or nursing staff in elderly homes; (3) there
was no scheduled follow-up in the urology nurse clinic. TWOC
would be carried out by a surgical day ward nurse for individual
patients as prescribed by individual surgeons during consultation;
and (4) some patients were referred to a urology specialist clinic by
the orthopaedic doctor in charge or the surgeon after consultation.
Results
We performed all statistical analyses using SPSS software
(version 20.0; SPSS Inc., Chicago, IL, USA). We used Chi-square tests
Table 1
Demographic and clinical characteristics of patients
Characteristics Control group (n ¼ 110) Intervention group (n ¼ 140) p*
Age
Mean (SD) 83.76 (7.00) 85.52 (6.92) 0.048
Median (range) 85.00 (69e98) 86.00 (66e102)
Sex
Male 34 (30.9) 29 (20.7) 0.078
Female 76 (69.1) 111 (79.3)
Fracture
Neck of femur 45 (40.9) 77 (55.0) 0.027
Trochanter 65 (59.1) 63 (45.0)
Surgery
Arthroplasty 36 (32.7) 63 (45.0)
CRIF 74 (67.3) 77 (55.0) 0.052
Comorbidity
With cerebral vascular disease 7 (6.4) 5 (3.6) 0.377
With parkinsonism 1 (0.9) 2 (1.4) >0.99
With diabetes mellitus 14 (12.7) 28 (20.0) 0.172
With dementia 1 (0.9) 6 (4.3) 0.139
With benign prostate hypertrophy 12 (10.9) 13 (9.3) 0.677
With Ca prostate 1 (0.9) 4 (2.9) 0.388
Drugs for benign prostate hypertrophy
On antiadrenergic agents (Doxazosin, Terazosin or
Prazosin hydrochloride)
11 (10.0) 8 (5.7) 0.235
Length of stay
Mean (SD) 39.88 (17.12) 40.96 (18.58) 0.639
Median (range) 37.00 (17e127) 39.00 (5e122)
Data are presented as frequency (%), unless otherwise indicated.
SD ¼ standard deviation; CRIF ¼ closed reduction and internal ﬁxation.
* Chi-square for proportions, t test for continuous variables. p < 0.05.
Table 2
Comparison of outcomes of trial without a catheter
Conducting a trial for removal of urinary catheter (%) Control group (n ¼ 110) Intervention group (n ¼ 140) c2 p
n (%) n (%)
Successful removal of urinary catheter in orthopaedic wards before discharge 42 (38.2) 96 (68.6) 23.005 <0.001y
Successful removal of urinary catheter by community nurses 0 (0.0) 19 (13.6) d d
Successful removal of urinary catheter in urology nurse clinic 0 (0.0) 9 (6.4) d d
Successful removal of urinary catheter in surgical day ward 20 (18.2) 0 (0.0) d d
Removal tried, but failed with long-term urinary catheter 8 (7.3) 16 (11.4) 1.226 0.268
Removal not tried with long-term urinary catheter 40 (36.4) 0 (0.0) d d
* Chi-square for proportions.
y p < 0.001.
Table 3
Comparison of urinary catheter time for successful TWOC in control and intervention groups*
Catheter time (d) Control group (n ¼ 110) Intervention group
(n ¼ 140)
t p
n (%) Mean (SD) n (%) Mean (SD)
Successful removal of urinary catheter in orthopaedic wards before discharge 42 (38.2) 31.40 (12.06) 96 (68.6) 18.55 (16.54) 4.533 <0.001y
Successful removal of urinary catheter by community nurses 0 (0.0) 0 (0.0) 19 (13.6) 63.42 (10.60) d d
Successful removal of urinary catheter in urology nurse clinic 0 (0.0) 0 (0.0) 9 (6.4) 88.33 (18.54) d d
Successful removal of urinary catheter in surgical day ward 20 (18.2) 130.85 (103.73) 0 (0.0) 0 (0.0) d d
Total catheter time 62 (63.5) 63.48 (75.14) 124 (30.5) 30.49 (27.81) 4.340 <0.001y
SD ¼ standard deviation; TWOC ¼ trial without catheter.
* Patients with failed TWOC were excluded.
y p < 0.001.
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compare the changes of continuous variables between groups.
Statistical signiﬁcance was conferred by a two-tailed p value of
 0.05. The groups were comparable in terms of baseline charac-
teristics (Table 1). The rate of successful catheter removal (Table 2),
duration required for successful catheter removal (Table 3), and
number of episodes of UTI (Table 4) were reported. Finally, the
length of hospital stay in both the intervention group and the
control group was also studied.Patients in the intervention group achieved a higher rate of
successful TWOC (p < 0.001, Table 2). The indwelling urethral
catheters were successfully removed in 96 patients (68.6%) in or-
thopaedic wards before they were discharged. The catheters were
successfully removed in 28 more patients in the community, of
which 19 (13.6%) were removed by community nurses and 9 (6.4%)
in a urology nurse clinic. The overall successful rate of TWOC was
88.6%. In the control group, 42 patients (38.2%) had their catheters
removed successfully before discharge, and 20 (18.2%) had their
Table 4
Comparison of urinary tract infection before removal of urinary catheter in control and intervention groups*
Episodes of urinary tract infection Control group (n ¼ 110) Intervention group (n ¼ 140) c2 p
n (%) n (%)
No urinary tract infection 17 (15.5) 83 (59.3) 32.151y 0.001z
One episode of urinary tract infection 23 (20.9) 31 (22.1)
More than 1 episode of urinary tract infection 22 (20.0) 10 (7.1)
TWOC ¼ trial without catheter.
* Patients with failed TWOC were excluded.
y Chi-square test.
z p < 0.001.
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failed in TWOC and required a permanent catheter upon discharge.
Forty patients (36.4%) were discharged with catheters being placed
permanently without a TWOC. The overall successful rate of TWOC
was 56.4%. Despite TWOC, 16 patients (11.4%) in the intervention
group and 8 patients (7.3%) in the control group required perma-
nent catheters.
Table 3 demonstrates the catheter mean time for patients with
successful TWOC. With a structured and standardized protocol, the
catheter time was signiﬁcantly shorter in the intervention group
(p < 0.001). The mean catheter time was 18.55 days in the hospital
phase, 63.42 days in the community nursing phase, and 88.33 days
in the urology nursing phase. By contrast, the mean catheter time
was 31.40 days in the hospital phase and 130.85 days in the surgical
day ward phase in the control group. The episodes of UTI were
much lower in the intervention group (p < 0.001, Table 4). More-
over, the ﬁrst urology specialist clinic appointment was shortened
from 59 weeks to 16 weeks in the intervention group.
Discussion
AROU is not a rare complication after hip fracture.18e20 The re-
ported incidence rate has been as high as 82% before surgery2 and
56% after surgery.21 Unfortunately, it tends to be overlooked in
clinical situations because it can simply be relieved by placing an
indwelling urethral catheter. However, the presence of an
indwelling urethral catheter may create more complications, yet
the underlying urological problems are not solved. In general, the
duration of keeping the indwelling urethral catheters in situ, fre-
quency of trials of catheter removal, plan of further investigations,
and decision regarding consultationwith a urologist depend on the
attending physician's judgement. Under such circumstances, it is
not surprising that indwelling urethral catheters were placed
permanently without urological assessment in up to one-third of
the patients.
The TWOC protocol is a document with the aim of guiding de-
cisions in managing AROU. It guides various healthcare pro-
fessionals to take care of patients suffering from AROU after hip
fracture surgeries from hospital to community. Trial of removal of
catheter is scheduled, and in case of failure of removal before
discharge, the pathway of further trials in the community and the
responsible personnel are well documented. It helps reduce vari-
ation in practice, streamline the caring process, and ensure efﬁcient
utilization of resources. It contains an algorithm of risk manage-
ment when obstructive uropathy is suspected. It guarantees timely
input from urologists. Most important of all, follow-up appoint-
ments with a urologist was sped up to manage the urological pa-
thology promptly. With this protocol in place, the care giver was
well informed and the anxiety was greatly reduced.
Although all patients in both groups expressed that they could
urinate normally before admission, no examination for voiding
dysfunction was carried out before the operation. Moreover, some
studies showed that spinal and opiate anaesthesia could induceurinary retention.22e24 Therefore, it is important to assess patients
and provide adequate opportunity for the trial of removal of the
indwelling urethral catheters before the catheters are placed
permanently.18 The trial of catheter removal should be allowed
throughout the acute and rehabilitation phases, and should be
continued in the community in case of a failure of removal of the
catheter during the hospital stay. With the TWOC programme, the
entire process is carried out and monitored by trained pro-
fessionals. This can maximize the chance of successful catheter
removal and reduce the catheter time.
In the past, there were no standard criteria to deﬁne AROU, and
bladder scanning was not performed in every patient suspected to
have AROU. Moreover, patients with AROU with overﬂow inconti-
nence were always missed, because some healthcare workers
misunderstood that “wet napkin” meant that the patient was able
to void normally. Thus, the treatment and follow-up actions to-
wards the management of AROU varied among patients. After the
implementation of the TWOC programme, all geriatric hip fracture
patients with AROU received standardized and timely treatment
and investigations, and would have an early assessment by urology
nurses and urologists if indicated. Moreover, bladder scanning was
performed routinely from the time of admission and when AROU
was suspected. This helped us detect AROU early, and eliminate the
expressive problems in patients with advanced age or cognitive
impairment who had difﬁculty in expressing their needs. Wemight
have insertedmore indwelling urethral catheters than before, but it
was simply due to the fact that we were able to identify more pa-
tients who suffered from AROU. In fact, we were able to wean off
most of the indwelling urethral catheters that were inserted when
the patient was undergoing the management pathway for geriatric
hip fractures. The overall rate of successful removal of indwelling
urethral catheters before the patients were discharged from the
hospital improved signiﬁcantly from 38.2% to 68.6% (p < 0.001).
Although a higher rate of successful catheter removal may be
related to a lower insertion threshold and more chances were
provided for the trial of removal, the improvement in the overall
rate of successful TWOC was contributed by early detection and
treatment of UTI, routine and repeated bladder scanning, additional
chances for the trial of catheter removal, and increased awareness
of UTI and AROU among medical and nursing staff.
The TWOC programme not only enhances the awareness of
AROU among nursing staff, but also provides more chances for the
trial of catheter removal. This improvement is also reﬂected by the
signiﬁcantly shorter duration of catheter time (Table 3) in the
intervention group. In those patients who had the indwelling
urethral catheters successfully removed before discharge from
hospital, the mean catheter timewas 18.55 days in the intervention
group, but 31.4 days in the control group. In the past, if removal of
catheters failed before discharge, the trial of removal could only be
attempted during attendance to the surgical day ward, and the
mean catheter timewas> 4months for thosewhose catheters were
ﬁnally removed successfully. With the TWOC programme, the trial
of catheter removal was also performed by community and urology
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cessful catheter removal. Moreover, patients were no longer being
discharged without the trial of removal of the indwelling urethral
catheters.
It has been reported that the risk of UTI was directly related to
the duration of catheterizationdestimated to be 5e10% per cath-
eter day beyond the ﬁrst 48 hours of catheterization.25,26 A
reduction in catheter time should decrease the rate of UTI. Table 4
shows the episodes of UTI in the control and intervention groups.
The overall episodes of UTI were signiﬁcantly lower in the inter-
vention group. Moreover, the number of patients who were free
from UTI throughout the period with indwelling urethral catheters
in situ was signiﬁcantly higher in the intervention group.
It is not uncommon that patients and families are unwilling to
go home with the presence of indwelling urethral catheters. The
TWOC programme provides continuation of care to the patients by
urological professionals, and we believed that it helps reduce the
duration of unnecessary hospital stay. Nevertheless, the length of
stay between the intervention group and the control group was
similar. The mean hospital stay was around 40 days in both groups.
It implies that the length of stay is affected by factors other than the
presence of indwelling urethral catheters.
Limitations
We may have missed some cases of AROU in the control group
since bladder scans was not routinely performed. Moreover, since
urinary catheter was inserted in a higher residual urine volume in
the control group, the proportion of patients who required per-
manent catheterization may be affected.
AROU may be due to UTI in some patients. These patients were
expected to have successful TWOC after treatment of UTI. The
overall rate of catheter removal may be affected. The current study
could not eliminate this factor.
We changed the urethral catheter every 2 weeks because it is a
common practice for those who require long-term urethral cathe-
ters. It needs further studies to determine the optimal duration of
catheterization before TWOC.
Knowledge of the urological diagnosis, management, and
outcome of patients who attended the urology specialist clinic may
further help explain the reason of failure of TWOC in some patients,
and this information may strengthen our study.
Conclusion
The TWOC programme provides structured and standardized
urological management for patients suffering from AROU after
geriatric hip fracture surgeries. To reiterate, indwelling urethral
catheters must not be placed permanently without carrying out
urological assessment in patients with geriatric hip fractures.
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